Thr299
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr299  -  PGC-1 alpha (human)

Site Information
AGLtPPTtPPHKANQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448009

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 2 ) , electrophoretic mobility shift ( 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 2 )
Relevant cell line - cell type - tissue:
'muscle, skeletal' ( 2 ) , BOSC ( 2 ) , C2C12 (myoblast) ( 2 )

Upstream Regulation
Putative in vivo kinases:
P38A (human) ( 2 )
Kinases, in vitro:
P38A (human) ( 2 )
Treatments:
SB202190 ( 2 )

Downstream Regulation
Effects of modification on PGC-1 alpha:
protein stabilization ( 2 )

References 

1

Guo A (2010) CST Curation Set: 9885; Year: 2010; Biosample/Treatment: cell line, no cells/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

2

Puigserver P, et al. (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8, 971-82
11741533   Curated Info